Compare CHRS & OGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHRS | OGI |
|---|---|---|
| Founded | 2010 | 2013 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.0M | 174.3M |
| IPO Year | 2014 | 2015 |
| Metric | CHRS | OGI |
|---|---|---|
| Price | $1.82 | $1.48 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $5.51 | N/A |
| AVG Volume (30 Days) | ★ 1.7M | 773.8K |
| Earning Date | 04-06-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 109.88 | N/A |
| EPS | ★ 1.77 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $20.10 |
| Revenue Next Year | $79.63 | $13.92 |
| P/E Ratio | ★ $0.99 | $13.91 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.72 | $0.85 |
| 52 Week High | $2.62 | $2.24 |
| Indicator | CHRS | OGI |
|---|---|---|
| Relative Strength Index (RSI) | 52.42 | 50.82 |
| Support Level | $1.55 | $1.47 |
| Resistance Level | $1.89 | $1.51 |
| Average True Range (ATR) | 0.09 | 0.07 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 90.57 | 80.00 |
Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its strategy is to expand the use of LOQTORZI in NPC and advance the development of new indications for LOQTORZI in combination with both its pipeline candidates as well as its industry partners, driving synergies from proprietary combinations, including first-in-class anticancer agents. Its portfolio includes LOQTORZI, CHS-114, and Casdozokitug.
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.